Eli Lilly just announced phase 3 clinical trial results for its new medication, retatrutide, and it could become the most ...
US Weekly on MSN
Claudia Oshry Shares She’s Taking Weight Loss Drugs Again After Giving Birth: ‘War Is Over’
Claudia Oshry got real about her postpartum body. Oshry, 31, took to Instagram on Monday, December 15, to share that she’s ...
The best weight loss medication for men includes semaglutide (Ozempic , Wegovy ), tirzepatide (Mounjaro , Zepbound ), and ...
The influencer has been sharing her postpartum health journey, adding GLP-1 medication to her Weight Watchers program.
10hon MSN
Where Will Eli Lilly Be in 10 Years?
Eli Lilly is leading the market for GLP-1 medications (for weight loss and diabetes). In a decade, Eli Lilly could be in the ...
12hon MSN
Popular Weight-Loss Drugs Like Wegovy Fail To Lower Obesity-Related Cancer Risks, Study Finds
Researchers analysed 48 previously-conducted trials which examined the safety and efficacy of GLP-1 drugs on people with type ...
LLY's explosive GLP-1 growth, deep obesity pipeline and strong estimate momentum give it the edge over MRK despite a richer valuation.
Bariatric doctors who regularly prescribe GLP-1s share how long the worst Ozempic side effects last, and the best ways to ...
4hon MSN
Is Eli Lilly a Buy Before 2026?
Eli Lilly’s next-generation obesity treatment may prove highly effective for patients who have high BMI or suffer from ...
MarketBeat on MSN
Pfizer Adds to Its Big Bet on Weight Loss Drugs
Health care stocks have been on a run lately, leading the S&P 500’s 11 sectors over the past three months with a gain of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results